Lila Sciences Raises $350 million Series A
Lila Sciences has raised $350M in Series A funding led by Flagship Pioneering, with participation from Flagship Pioneering, Various. AI-Designed Antibodies Are Racing Toward Clinical Trials The funds will be used to Advance drug candidates into Phase 1.
What it does
AI-Designed Antibodies Are Racing Toward Clinical Trials This addresses protein Engineering Market Size, Share, Growth, Report, 2034.
Traction
Protein Engineering Market Size, Share, Growth, Report, 2034 The company is in the early stages of growth, with the Series A round serving as the clearest current traction signal in the source bundle.
Trend impact
Protein Engineering Market Size, Share, Growth, Report, 2034 As adoption in Healthcare & Life Sciences expands, focused products from Lila Sciences can pressure incumbents or broader platforms that do not address the same problem directly.
Funding history
- October 1, 2025 · Series A · $350 million · Flagship Pioneering
Products & services
- ByteDance, Baidu, Tencent, Alibaba, and JD capability
- How Internet Giants Are Making Different Choices in AI Drug Discovery capability
- Kr. ByteDance, Baidu, Tencent, Alibaba, and JD capability
- Kr Novel Therapeutic Modalities Target the Undruggable - Genetic capability
- Engineering and Biotechnology News. Novel Therapeutic Modalities Target capability